scholarly journals Cardioverter-Defibrillator Implantation to Treat Cardiac Fibroma-Induced Ventricular Tachycardia in a 70-Year-Old Woman

2014 ◽  
Vol 41 (3) ◽  
pp. 329-331 ◽  
Author(s):  
Fayaz Ahmad Hakim ◽  
Anil Pandit ◽  
Farouk Mookadam ◽  
Sylvia Mamby
Keyword(s):  
Ventricular Tachycardia ◽  
Implantable Cardioverter Defibrillator ◽  
Clinical Symptoms ◽  
Surgical Excision ◽  
Orthotopic Heart Transplantation ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Cardiac Fibroma ◽  
Outflow Obstruction ◽  
Cardioverter Defibrillator

Benign cardiac fibroma is rarely reported in adults. Its clinical symptoms are related to outflow obstruction or dysrhythmias. We present the case of a 70-year-old woman who had a syncopal episode from ventricular tachycardia caused by cardiac fibroma. Because of unfavorable tumor anatomy, the patient was not a candidate for surgical excision, and she declined orthotopic heart transplantation. To prevent sudden cardiac death, we placed an implantable cardioverter-defibrillator, and the patient remained well throughout the 2-year follow-up period. To our knowledge, this is the first report of implantable cardioverter-defibrillator therapy to treat an adult patient's unresectable cardiac fibroma.

scholarly journals Inducible Ventricular Tachycardia Due to Dermatomyositis-Related Cardiomyopathy in the Era of Implantable Cardioverter-Defibrillator Therapy

Circulation ◽  
2012 ◽  
Vol 125 (7) ◽  
pp. 967-969 ◽  
Author(s):  
Polychronis Dilaveris ◽  
Panagiota Pietri ◽  
Dimitris Tsiachris ◽  
Konstantinos Gatzoulis ◽  
Christodoulos Stefanadis
Keyword(s):  
Ventricular Tachycardia ◽  
Implantable Cardioverter Defibrillator ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Cardioverter Defibrillator

scholarly journals Surgery for Ventricular Tachycardia

2021 ◽  
pp. 36-42
Author(s):  
Gerald M Lawrie
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Implantable Cardioverter Defibrillator ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Surgical Ablation ◽  
Cardioverter Defibrillator ◽  
Automatic Implantable Cardioverter Defibrillator ◽  
Improved Methods

The treatment of drug-refractory chronic ventricular tachycardia (VT) has undergone a revolution over the last 50 years. We now have automatic implantable cardioverter defibrillator therapy with pace-terminating capabilities, and catheter ablation of VT has refined mapping and improved methods of lesion generation. Between 1980 and 1993, Houston Methodist Hospital became a leader in the diagnosis and surgical ablation of VT and other arrhythmias. This is a brief account of that period and some of the experiences and lessons that have led to significant advances used today.

Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients

EP Europace ◽  
2019 ◽  
Vol 21 (10) ◽  
pp. 1519-1526
Author(s):  
Lennart J Blom ◽  
Marloes Visser ◽  
Imke Christiaans ◽  
Marcoen F Scholten ◽  
Marianne Bootsma ◽  
...  
Keyword(s):  
Cardiac Arrest ◽  
Ventricular Fibrillation ◽  
Implantable Cardioverter Defibrillator ◽  
Recurrent Events ◽  
Risk Haplotype ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Idiopathic Ventricular Fibrillation ◽  
Icd Therapy ◽  
Cardioverter Defibrillator

Abstract Aims Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden cardiac arrest. Implantable cardioverter-defibrillator (ICD) implantation is currently the only treatment option. Limited data are available on the prevalence and complications of ICD therapy in these patients. We sought to investigate ICD therapy and its complications in patients with IVF. Methods and results Patients were selected from a national registry of IVF patients. Patients in whom no underlying diagnosis was found during follow-up were eligible for inclusion. Recurrence of ventricular arrhythmia (VA) was derived from medical and ICD records, electrogram records of ICD therapies were used to differentiate between appropriate or inappropriate interventions. Independent predictors for appropriate ICD shock were calculated using cox regression. In 217 IVF patients, recurrence of sustained VAs occurred in 66 patients (30%) during a median follow-up period of 6.1 years. Ten patients died (4.6%). Thirty-eight patients (17.5%) experienced inappropriate ICD therapy, and 32 patients (14.7%) had device-related complications. Symptoms before cardiac arrest [hazard ratio (HR): 2.51, 95% confidence interval (CI): 1.48–4.24], signs of conduction disease (HR: 2.27, 95% CI: 1.15–4.47), and carrier of the DPP6 risk haplotype (HR: 3.24, 1.70–6.17) were identified as independent predictors of appropriate shock occurrence. Conclusion Implantable cardioverter-defibrillator therapy is an effective treatment in IVF, treating recurrences of potentially lethal VAs in approximately one-third of patients during long-term follow-up. However, device-related complications and inappropriate shocks were also frequent. We found significant predictors for appropriate ICD therapy. This may imply that these patients require additional management to prevent recurrent events.

Sign in / Sign up

Export Citation Format

Share Document